Skip to main content

Table 4 Adverse drug event occurrence across different cancer types

From: Adverse drug events and contributing factors among pediatric cancer patients at Jimma University medical center, Southwest Ethiopia

Diagnosis

Number of ADE

Percent

Hematology malignancy

 ALL

156

33.46

 HL

71

15.24

 AML

43

9.23

 DLBCL

36

7.73

 ALCL

30

6.44

Solid tumors

 Rhabdomyosarcoma

41

8.80

 Wilm's tumor

35

7.51

 Osteosarcoma

23

4.94

 Retinoblastoma

13

2.79

 Hepatoblastoma

11

2.36

Others

7

1.50

Total

466

100

  1. Abbreviations: ALL acute lymphocytic leukemia, HL Hodgkin’s lymphoma, AML acute myeloid leukemia, DLBCL diffuse large B-cell leukemia, ALCL anaplastic large-cell leukemia
  2. Others: Nasopharyngeal carcinoma, Ewing sarcoma and Langerhans cell histocytosis
Back to article page

BMC Pediatrics

ISSN: 1471-2431

Contact us